What are Bill Gates' suggestions to prevent the next pandemic?

And what is the alarming warning that came in a recent American study about Omicron?

And how does Corona accelerate aging by twenty years in some patients?

In his book "How to Prevent the Next Pandemic?", Microsoft founder Bill Gates offers proposals to nip infection in the bud.

The Economist website published a report citing excerpts from the book.

Gates proposes creating a global "emergency team" of 3,000 experts spread around the world, recruiting based on skills based on areas as diverse as epidemiology and genetics, drug and vaccine development, computer modeling, and even diplomacy.

And this team - which is likely to work under the auspices of the World Health Organization - will remain in a permanent state of readiness, ready to respond to any outbreak discovered, proposing that this team be called - in principle - the name “GERM”, which is an abbreviation for “Global Epidemic Response and Mobilisation", which stands for global response to epidemics and mobilization.

Gates estimates that the GERM group will cost about $1 billion a year, and its team will be employed to strengthen the global infrastructure to combat the epidemic - and this is what diplomatic measures will do - by pushing governments to spend necessary on detecting, monitoring and suppressing potential outbreaks. and intensify the exercises.

Bill Gates List

On the technology side, Bill Gates' list includes: Designing and agreeing on protocols for rapid mass testing of drugs that may act against specific pathogens if an outbreak occurs.

Gates also wants to improve vaccine manufacturing and distribution, and to improve the vaccines themselves, especially by eliminating cooling problems, as most existing vaccines are sensitive to temperature, and must move quickly from one refrigerator to another on their way to clinics, while Gates recommends research in developing Heat resistant vaccines.

For pathogens that spread through the air, Bill Gates thinks a sophisticated approach to prevention is best: nasal sprays that contain drugs that bind to cell-surface proteins that viruses use to enter, thus depriving them of the means to reach target cells.

People with COVID who require hospitalization may experience cognitive decline similar to 20 years of age

Some patients suffer from long-term cognitive decline accompanied by a degree of impairment associated with severe infection with the Covid-19 virus, according to a recent study.

And author Nicola Davis, in his report published in the British newspaper "The Guardian", says that research indicates that people with Covid and their cases required hospitalization, may experience cognitive difficulties similar to the degree of aging of 20 years.

Cambridge University professor and lead author of the study, David Menon, explains that the degree of cognitive impairment is related to the severity of Covid infection.

"Covid causes problems to a range of parts of the body, including the brain, and affects cognitive function and mental health. If you can take all the doses of the vaccine, you will get less severe disease, and all these health problems will decrease."

slow information processing

In a report written by Menon and colleagues and published in the journal "eClinicalMedicine", they explained how they examined the results of cognitive tests that 46 patients underwent on average 6 months after their admission to Addenbrooke Hospital in Cambridge between March and July of 2020, where they 16 of them needed respirators.

The results indicated that those who spent their Covid treatment in hospital had certain cognitive problems, including slow information processing.

The study showed that although the cognitive difficulties were varied, the degree of change was similar to the cognitive decline experienced by people aged 50 to 70.

The team did not find a significant difference in the level of cognitive impairment between those who took the tests 6 months after their admission to the hospital, and the patients who were tested 10 months later despite there being indications of improvement.

An American study: Omicron is no less severe than other Covid mutant

A preliminary version of a large American study - reported by Reuters - reported that the severity of the omicron mutant of the Corona virus is in fact no different from the previous mutant, a study that contradicts assumptions in other studies that indicate that it is more capable of spreading, but less severe.

Experts said the results, which estimated omicron sharpness after taking into account the effect of vaccines, should reinforce the importance of vaccinations and booster doses.

Vaccines helped make hospitalization rates and deaths relatively low, with omicron infections increasing compared to the previous mutant.

The study, which is under review in the journal Nature Portfolio, was published in Research Square on May 2.

Its authors, from Massachusetts General Hospital, University of Minerva and Harvard Medical School, declined to comment before the review was completed.

"We found that the odds of hospitalization and mortality were nearly identical" between the Omicron era and other times in the past two years when other variables predominated, the researchers said in their report.

The US Drug Agency allocates Johnson's vaccine to those who refuse other vaccines

The US Drug Agency announced on Thursday that it will limit the use of the Johnson & Johnson vaccine against the Corona virus to adults who refuse to receive the “Pfizer” and “Moderna” vaccines due to “personal concerns” or other reasons. medical.

The agency said it made the decision due to the risk of serious clots associated with the Johnson & Johnson vaccine.

For the same reason, the Centers for Disease Control and Prevention - which is the largest body to oversee public health in the country - recommended last December the use of the Moderna and Pfizer vaccines instead of Johnson & Johnson.

These three vaccines are the only ones allowed in the United States.

This decision was built into the license for emergency use of the Johnson & Johnson vaccine.


The agency counted 60 confirmed cases of blood clots in the United States, including 9 deaths.

Less than 19 million doses of the Johnson & Johnson vaccine were given in the country, about 3% of the total doses injected.

The rate of blood clots as a result of the vaccine was 3.23 per million doses, according to the US Agency.

"However, we are aware that the Johnson anti-Covid vaccine continues to play a role in responding to the current pandemic," agency official Peter Marks said in a statement.

The agency cited 3 examples of people who could still receive the J&J vaccine: individuals who are at risk of severe allergic reactions to mRNA vaccines such as Pfizer and Moderna, and who have difficulty accessing the last two vaccines due to their lack of availability. .

Finally, individuals who “have personal concerns about receiving an mRNA vaccine and would for that reason remain unvaccinated.”